Keyphrases
Age at Diagnosis
25%
Age of Onset
25%
Arthritis
25%
Autoimmune Hepatitis
25%
Autoimmunity
100%
Bone Marrow Transplantation
25%
Cellular Immunodeficiency
25%
Clinical Manifestations
25%
Clinical Symptoms
25%
Double Negative
25%
Early Identification
25%
Early Onset
100%
Endocrinopathy
25%
Enteropathy
25%
Gain-of-function
100%
Gain-of-function mutation
25%
Gain-of-function Variant
50%
Germ Cells
50%
Growth Delay
25%
Humoral Immunodeficiency
25%
Immune Dysregulation
25%
Immune Thrombocytopenia
50%
Immune-mediated Diseases
25%
Immunosuppressive Therapy
25%
Inclusion Criteria
25%
International Cohort
25%
JAK Inhibitors
25%
Lifesaving
25%
Lymphoproliferation
100%
Monogenic
100%
Multisystem
25%
Multisystem Disease
25%
Natural History
100%
Neurological Diseases
25%
Overall Survival
50%
Patient Care
25%
Prompt Treatment
25%
Pulmonary Disease
25%
Renal Disease
25%
Renal Malignancy
25%
Signal Transducer and Activator of Transcription 3
25%
Skin Diseases
25%
Survival Rate
25%
Symptom Onset
25%
T Cells
25%
Treatment Implementation
25%
Treatment Modalities
25%
Treatment Strategy
25%
Treatment Survival
25%
Unique mutation
25%
Vasculopathy
25%
Medicine and Dentistry
Arthritis
20%
Autoimmune Hepatitis
20%
Autoimmunity
100%
Bone Marrow Transplantation
20%
Cancer
20%
Cohort Analysis
20%
Cytopenia
40%
Dermatosis
20%
Diseases
20%
Endocrine Disease
20%
Enteropathy
20%
Gain of Function Mutation
20%
Germ Cell
40%
Immune Deficiency
20%
Immune Dysregulation
20%
Infection
20%
Janus Kinase Inhibitor
20%
Lymphocyte Proliferation
100%
Nephropathy
20%
Neurologic Disease
20%
Onset Age
20%
Overall Survival
40%
Patient Care
20%
Silo-Filler's Disease
20%
STAT3 Protein
20%
Survival Rate
20%
Systemic Disease
20%
T Cell
20%
Vascular Disease
20%
Immunology and Microbiology
Arthritis
16%
Autoimmune Hepatitis
16%
Autoimmunity
100%
Bone Marrow Transplantation
16%
Gain of Function Mutation
16%
Germ Cell
33%
Immune Dysregulation
16%
Immunodeficiency
16%
Lymphocyte Proliferation
100%
Overall Survival
33%
STAT3
100%
Survival Rate
16%
T Cell
16%